Literature DB >> 19760671

Effect of reactive-aldehydes on the modification and dysfunction of human serum albumin.

Katsumi Mera1, Kazuhiro Takeo, Miyoko Izumi, Toru Maruyama, Ryoji Nagai, Masaki Otagiri.   

Abstract

Advanced glycation end products (AGEs) are generated not only from glucose but also from several aldehydes such as methylglyoxal, glyoxal, and glycolaldehyde. The aim of the present study was to investigate the effect of several aldehydes on human serum albumin (HSA) in terms of the physicochemical properties and formation of AGE structures. HSA modified with methylglyoxal, generated by the glycolysis pathway and degradation of the Schiff base, showed the highest increase in the molecular weight and net negative charge, whereas glucose modification caused a small increase in the molecular weight even incubation for after 4 weeks. N(epsilon)-(carboxymethyl)lysine (CML), N(epsilon)-(carboxyethyl)lysine (CEL), and imidazolone increased in modified HSA in correlation with their lysine and arginine modification, whereas high amounts of GA-pyridine was detected in HSA modified with glycolaldehyde. Furthermore, the binding ability of HSA to warfarin and ketoprofen was more effectively decreased by methylglyoxal modification than the other aldehydes. These results indicated that changes in the physicochemical properties and the formation of AGE structures are highly dependent on the aldehydes. 2009 Wiley-Liss, Inc. and the American Pharmacists Association

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19760671     DOI: 10.1002/jps.21927

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  11 in total

1.  Unexpected crosslinking and diglycation as advanced glycation end-products from glyoxal.

Authors:  Andrea F Lopez-Clavijo; Carlos A Duque-Daza; Andrew Soulby; Isolda Romero Canelon; Mark Barrow; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2014-10-15       Impact factor: 3.109

Review 2.  Antibody-based detection of advanced glycation end-products: promises vs. limitations.

Authors:  Ryoji Nagai; Jun-Ichi Shirakawa; Rei-Ichi Ohno; Kota Hatano; Hikari Sugawa; Shoutaro Arakawa; Kenta Ichimaru; Shoh Kinoshita; Noriyuki Sakata; Mime Nagai
Journal:  Glycoconj J       Date:  2016-07-15       Impact factor: 2.916

3.  Multiphoton imaging of the glomerular permeability of angiotensinogen.

Authors:  Daisuke Nakano; Hiroyuki Kobori; James L Burford; Haykanush Gevorgyan; Saskia Seidel; Hirofumi Hitomi; Akira Nishiyama; Janos Peti-Peterdi
Journal:  J Am Soc Nephrol       Date:  2012-09-20       Impact factor: 10.121

4.  Glycolaldehyde, an Advanced Glycation End Products Precursor, Induces Apoptosis via ROS-Mediated Mitochondrial Dysfunction in Renal Mesangial Cells.

Authors:  Min Ji Gu; Ju-Youg Hyon; Hee-Weon Lee; Eun Hee Han; Yoonsook Kim; Youn-Soo Cha; Sang Keun Ha
Journal:  Antioxidants (Basel)       Date:  2022-05-09

5.  The interplay between copper(II), human serum albumin, fatty acids, and carbonylating agent interferes with Cys 34 thiol reactivity and copper binding.

Authors:  Ana Z Penezić; Jelena M Aćimović; Ivan D Pavićević; Vesna B Jovanović; Marija Takić; Ljuba M Mandić
Journal:  J Biol Inorg Chem       Date:  2018-11-19       Impact factor: 3.358

6.  Study of an unusual advanced glycation end-product (AGE) derived from glyoxal using mass spectrometry.

Authors:  Andrea F Lopez-Clavijo; Carlos A Duque-Daza; Isolda Romero Canelon; Mark P Barrow; David Kilgour; Naila Rabbani; Paul J Thornalley; Peter B O'Connor
Journal:  J Am Soc Mass Spectrom       Date:  2014-01-28       Impact factor: 3.109

7.  Association between Advanced Glycation End Products and Impaired Fasting Glucose: Results from the SALIA Study.

Authors:  Tom Teichert; Anne Hellwig; Annette Peßler; Michael Hellwig; Mohammad Vossoughi; Dorothea Sugiri; Andrea Vierkötter; Thomas Schulte; Juliane Freund; Michael Roden; Barbara Hoffmann; Tamara Schikowski; Christian Luckhaus; Ursula Krämer; Thomas Henle; Christian Herder
Journal:  PLoS One       Date:  2015-05-27       Impact factor: 3.240

8.  Cys34-cysteinylated human serum albumin is a sensitive plasma marker in oxidative stress-related chronic diseases.

Authors:  Kohei Nagumo; Motohiko Tanaka; Victor Tuan Giam Chuang; Hiroko Setoyama; Hiroshi Watanabe; Naoyuki Yamada; Kazuyuki Kubota; Motoko Tanaka; Kazutaka Matsushita; Akira Yoshida; Hideaki Jinnouchi; Makoto Anraku; Daisuke Kadowaki; Yu Ishima; Yutaka Sasaki; Masaki Otagiri; Toru Maruyama
Journal:  PLoS One       Date:  2014-01-08       Impact factor: 3.240

9.  Neutrophil Activation by Mineral Microparticles Coated with Methylglyoxal-Glycated Albumin.

Authors:  Elena V Mikhalchik; Victor A Ivanov; Irina V Borodina; Olga V Pobeguts; Igor P Smirnov; Irina V Gorudko; Daria V Grigorieva; Olga P Boychenko; Alexander P Moskalets; Dmitry V Klinov; Oleg M Panasenko; Luboff Y Filatova; Ekaterina A Kirzhanova; Nadezhda G Balabushevich
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

10.  Nω -(Carboxymethyl)arginine Is One of the Dominant Advanced Glycation End Products in Glycated Collagens and Mouse Tissues.

Authors:  Sho Kinoshita; Katsumi Mera; Hiroko Ichikawa; Satoko Shimasaki; Mime Nagai; Yuki Taga; Katsumasa Iijima; Shunji Hattori; Yukio Fujiwara; Jun-Ichi Shirakawa; Ryoji Nagai
Journal:  Oxid Med Cell Longev       Date:  2019-09-10       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.